Inhibition of the alpha-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine.

TitleInhibition of the alpha-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine.
Publication TypeJournal Article
Year of Publication2005
AuthorsJeitner TM, Xu H, Gibson GE
JournalJ Neurochem
Volume92
Issue2
Pagination302-10
Date Published2005 Jan
ISSN0022-3042
KeywordsAnimals, Cell Line, Tumor, Chloramines, Enzyme Activation, Hydrogen Peroxide, Hypochlorous Acid, Ketoglutarate Dehydrogenase Complex, Mice, Neuroblastoma, Oxidants, Peroxidase
Abstract

Abstract alpha-Ketoglutarate dehydrogenase (KGDHC) complex activity is diminished in a number of neurodegenerative disorders and its diminution in Alzheimer Disease (AD) is thought to contribute to the major loss of cerebral energy metabolism that accompanies this disease. The loss of KGDHC activity appears to be predominantly due to post-translation modifications. Thiamine deficiency also results in decreased KGDHC activity and a selective neuronal loss. Recently, myeloperoxidase has been identified in the activated microglia of brains from AD patients and thiamine-deficient animals. Myeloperoxidase produces a powerful oxidant, hypochlorous acid that reacts with amines to form chloramines. The aim of this study was to investigate the ability of hypochlorous acid and chloramines to inhibit the activity of KGDHC activity as a first step towards investigating the role of myeloperoxidase in AD. Hypochlorous acid and mono-N-chloramine both inhibited purified and cellular KGDHC and the order of inhibition of the purified complex was hypochlorous acid (1x) > mono-N-chloramine (approximately 50x) > hydrogen peroxide (approximately 1,500). The inhibition of cellular KGDHC occurred with no significant loss of cellular viability at all exposure times that were examined. Thus, hypochlorous acid and chloramines have the potential to inactivate a major target in neurodegeneration.

DOI10.1111/j.1471-4159.2004.02868.x
Alternate JournalJ Neurochem
PubMed ID15663478
Grant ListAG 11921 / AG / NIA NIH HHS / United States
AG 14930 / AG / NIA NIH HHS / United States
AG 19589 / AG / NIA NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065